SAM
AMRX icon

Sectoral Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Sectoral Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17,700
Closed -$84K – 94
2020
Q2 		$84K Buy
+17,700
New +$72.9K 0.01% 188
2018
Q4 		– Sell
-9,040
Closed -$201K – 107
2018
Q3 		$201K Buy
+9,040
New +$190K 0.02% 136

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sectoral Asset Management's AMRX Position: Q3 2020 in Review

Sectoral Asset Management sold out of Amneal Pharmaceuticals (AMRX) in Q3 2020, closing a stake of 17,700 shares — an estimated $84K sold.

Sectoral Asset Management first reported a position in AMRX in Q3 2018 and held it in 2 quarters. The position peaked at $201K in Q3 2018. 140 funds tracked by Wall St. Rank hold AMRX as of Q3 2020.

  • Sectoral Asset Management reported no remaining Amneal Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Sectoral Asset Management sold 17,700 Amneal Pharmaceuticals shares in Q3 2020, an estimated $84K.
  • Sectoral Asset Management first reported a position in Amneal Pharmaceuticals in Q3 2018 and held it in 2 quarters.
  • Sectoral Asset Management's Amneal Pharmaceuticals position peaked at $201K in Q3 2018.
  • 140 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2020.

Based on Sectoral Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.